Weight Watchers Adds $25-Monthly Ozempic Pill to Med+ Diabetes Program
WW•Weight Watchers will offer FDA-approved Ozempic pill (semaglutide) to Med+ members with type 2 diabetes, providing a once-daily oral GLP-1 option. Eligible members can leverage insurance to reduce monthly prescription costs to as low as $25 while receiving clinical support and diabetes nutrition coaching.
1. Med+ Adds Oral Ozempic Option
Weight Watchers has integrated Novo Nordisk’s FDA-approved Ozempic pill into its Med+ offering for adults with type 2 diabetes, providing a once-daily oral semaglutide alternative alongside existing GLP-1 treatments.
2. Insurance and Cost Support
Members can leverage insurance coverage to reduce monthly prescription costs to as low as $25, with Weight Watchers assisting on prior authorization, utilization management, and cash-pay pathways.
3. Comprehensive Diabetes Support Program
Med+ members receive care from board-certified clinicians, tailored nutrition coaching, virtual and in-person community, and a blood sugar tracker; program participants saw a 0.75% HbA1c reduction over six months.
